New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 22, 2013
09:05 EDTCLSN, RIMM, DD, CAT, JNJ, TRV, NUS, VZOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Travelers (TRV), up 3.5%... DuPont (DD), up 0.9%... ALSO HIGHER: Research In Motion (RIMM), up 7.1% after CEO reportedly says may license new BB10 operating system to other companies, upgrade to Outperform at Scotia Capital... Celsion (CLSN), up 11.4% after entering technology development agreement... DOWN AFTER EARNINGS: Verizon (VZ), down 0.9%... Johnson & Johnson (JNJ), down 0.9%... ALSO LOWER: Nu Skin (NUS), down 3.2% after NY Post says Dan Loeb's Third Point took "sizable" short position... Caterpillar (CAT), down 1.8% after announcing plans for $580M Q4 charge for accounting misconduct at unit.
News For TRV;DD;VZ;JNJ;RIMM;NUS;CAT;CLSN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 20, 2015
10:52 EDTJNJFDA approves new oral medication to treat multiple myeloma
Subscribe for More Information
November 19, 2015
10:26 EDTCATGoldman says sell Titan with ag and mining weakness expected to continue
Goldman Sachs downgraded Titan International (TWI) to Sell from Neutral today, saying that weakness in agriculture and mining would continue to weigh on the company's results. Goldman's downgrade comes after the company reported much weaker than expected results on November 6. Titan makes tires and wheels used in off-road vehicles which are utilized by farmers and mining and construction companies. WHAT'S NEW Titan derives 80% of its revenue from agriculture and mining, so the weakness in those sectors will continue to hurt its results going forward, wrote Goldman analyst David Tamberino. Additionally, farmers have less money to spend on capital projects, reducing the likelihood that they will adopt Titan's new LSW tires, according to the analyst. Given these factors and the January 2017 maturity of Titan's convertible note, the company could be faced with a cash crunch, the analyst warned. Moreover, Titan is facing increased competition, according to Tamberino. He sharply lowered his 2015-2017 earnings before interest, taxes, depreciation and amortization estimates for the company and slashed his price target on the name to $3 from $8. WHAT'S NOTABLE: Deere (DE), Caterpillar (CAT), and AGCO (AGCO) sell heavy machinery used in agriculture. PRICE ACTION: In early trading, Titan sank 11% to $4.50.
November 18, 2015
11:33 EDTVZSprint announces launch of LTE Plus network
In celebration of the launch of its new LTE Plus network, Sprint (S) is introducing the biggest wireless offer in U.S. history - 50% off the price of most Verizon (VZ), AT&T (T) and T-Mobile (TMUS) rate plans, the company says. New customers can sign up for this offer nationwide Nov. 20 through Jan. 7, 2016. LTE Plus, available today in 77 major markets, takes advantage of Sprint's rich triband spectrum portfolio, and it uses some of the world's most advanced technologies in wireless, such as carrier aggregation and antenna beamforming. Customers who switch get 50 percent off most current rate plan prices from their current carrier. AT&T, T-Mobile and Verizon customers switching to Sprint also can take advantage of iPhone Forever, where they are eligible to upgrade every time a new iPhone launches. Customers must port one line, and can add up to 9 additional lines on the account. Customers must choose from the 50 percent off rate plans available from their current carrier. Cricket and MetroPCS customers also can switch and save 50 percent off their parent company's postpaid rates. 50 percent off pricing remains valid until Jan. 8, 2018, for activations between Nov. 20, 2015, and Jan. 7, 2016.
08:11 EDTJNJIMS Health forecasts global drug spending to increase 30% by 2020 to $1.4T
Subscribe for More Information
08:11 EDTJNJAduro Biotech receives milestone payment from Janssen
Aduro Biotech (ADRO) announced that it has received a milestone payment from Janssen Biotech (JNJ) for Aduro's submission of an Investigational New Drug, or IND, Application to the FDA for ADU-741, a LADD immunotherapy product candidate for the treatment of prostate cancer. The IND will enable Janssen, Aduro's license partner for ADU-741, to initiate a multi-center Phase 1 trial to evaluate the safety and immunogenicity of intravenous administration of ADU-741 in patients with metastatic castration-resistant prostate cancer.
06:01 EDTDDMonsanto studying possibility for consolidation in agrochem sector, Reuters says
Subscribe for More Information
November 17, 2015
08:29 EDTDDDuPont price target raised to $76 from $63 at Citi
Subscribe for More Information
November 16, 2015
15:36 EDTCATCaterpillar November volatility up into overview of Financial Services
Subscribe for More Information
14:38 EDTJNJGenmab confirms FDA approval of Darzalex
Subscribe for More Information
13:29 EDTCATCaterpillar to host conference call
Subscribe for More Information
13:09 EDTJNJFDA approves Darzalex to treat multiple myeloma
Subscribe for More Information
November 13, 2015
12:34 EDTCATCaterpillar, General Motors, Altria Group are market beaters, Barron's says
Subscribe for More Information
November 12, 2015
19:41 EDTVZAT&T, Verizon ask FCC to limit Charter/Time Warner Cable merger, Bloomberg says
A trade group for AT&T (T) and Verizon (VZ) petitioned the FCC to limit Charter's (CHTR) coordination with other cable companies if the merger with Time Warner Cable (TWC) is allowed to proceed, reports Bloomberg. USTelecom also asked the FCC for restrictions on John Malone, Charter's largest shareholder. Reference Link
18:29 EDTDDSyngenta rejects initial $42B bid from ChemChina, Bloomberg says
Syngenta rejected that offer citing regulatory risk, however Syngenta and ChemChina are continuing talks, Bloomberg added. Syngenta is also talking to other suitors and has had previous discussions with both DuPont (DD) and Monsanto (MON) earlier this year. Reference Link

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use